CD8A and neoplasm: In a B16F10 tumor-bearing mouse model, 40 mg/kg of GS (IP) plus anti-CD8 antibody reduced the tumor volume and tumor weight by~55% and 65%, respectively, while this molecule increased the level of CD3+ T cells and CD8+ CTLs [52].